Market Overview

The Latin America hypodermic syringes and needles market size was valued at USD 207.12 Million in 2024 and is expected to grow to USD 365.07 Million by 2033. The market is projected to expand at a CAGR of 5.85% during the forecast period from 2025 to 2033. Growth is driven by expanding vaccination programs, increasing chronic disease prevalence, and enhanced healthcare infrastructure along with government initiatives and technological advancements.

Study Assumption Years

• Base Year: 2024
• Historical Period: 2019-2024
• Forecast Period: 2025-2033

Latin America Hypodermic Syringes and Needles Market Key Takeaways

• The market size reached USD 207.12 Million in 2024.
• Expected CAGR of 5.85% during 2025-2033.
• Forecast to reach USD 365.07 Million by 2033.
• Extensive government-led immunization and vaccination initiatives are fueling market growth, with influenza vaccine purchases in Argentina rising from 1.2 million to over 4 million doses by 2025.
• Rising government investments in healthcare infrastructure across Latin America facilitate access to medical supplies including syringes and needles.
• Increasing focus on sustainability encourages the development of biodegradable and recyclable syringes and needles, supported by regional eco-labeling programs.

Sample Request Link: https://www.imarcgroup.com/latin-america-hypodermic-syringes-needles-market/requestsample

Market Growth Factors

The Latin America hypodermic syringes and needles market growth is significantly driven by expanded immunization and vaccination programs led by governments. Notably, influenza vaccine purchases from Argentine suppliers are expected to grow from 1.2 million doses to over 4 million doses by 2025, enhancing regional vaccine access and cost efficiency. Collaborative efforts by Argentina's National Ministry of Health and the Pan American Health Organization (PAHO) further ensure safe, affordable health technologies. Public health campaigns targeting diseases like influenza and COVID-19 spur demand for high-quality syringes and needles, bolstering market stability and encouraging global supplier partnerships.

Increased government spending on healthcare infrastructure also positively impacts market prospects. Enhanced public health funding broadens access to essential medical supplies such as syringes and needles that are crucial for routine procedures and vaccination drives. Governments prioritize healthcare modernization and better patient care, exemplified by Brazil's 2024 aeromedical trade mission promoting U.S.-Brazil medical device partnerships. Brazil’s allocation of USD 40 million for aeromedical goods demonstrates the emphasis on forming strong supplier relationships, contributing to supply chain stability and market growth.

A growing focus on sustainability and environmentally friendly solutions influences the market trends in Latin America. The formation of the Environmental Alliance of America in 2024, backed by the UN Environment Programme and funded by Germany, introduces the first regional eco-labeling program. This initiative fosters sustainable trade and informs over 450 million consumers on product environmental impacts. As a result, manufacturers develop biodegradable and recyclable syringes and needles that reduce medical waste and environmental harm. Regulatory encouragement for greener manufacturing also fuels investments in sustainable medical device research and development, fostering an eco-conscious healthcare system.

Market Segmentation

Product Insights:

• Hypodermic Syringes: Includes conventional syringes and safety syringes, which comprise retractable and non-retractable safety syringes. These categories cover diverse syringe types facilitating various medical applications.
• Hypodermic Needles: Divided into conventional needles and safety needles, addressing different safety and medical performance requirements in healthcare.

End Use Insights:

• Hospitals: Major end users relying on a broad variety of syringes and needles for various clinical procedures.
• Clinics: Important usage hubs for routine injections and treatments.
• Ambulatory Surgical Centers: Facilities requiring specialized syringes and needles for outpatient surgeries.
• Veterinary: Usage in animal healthcare.
• Home Care: Growing segment focusing on patient self-administration and home treatments.
• Others: Encompasses additional end-use categories not separately specified.

Country Insights:

• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Peru
• Others

These countries collectively represent the major markets within Latin America, each contributing to market dynamics and growth.

Regional Insights

Brazil emerges as a dominant market in Latin America for hypodermic syringes and needles. The country benefits from growing aeromedical sector collaborations and a focused public procurement budget of USD 40 million for medical goods in 2024. This has fostered partnerships with suppliers, particularly from the U.S., to ensure steady product availability and market growth. Brazil’s strategic investments and initiatives underpin its leadership in regional hypodermic syringes and needles demand and supply.

Recent Developments & News

In September 2024, the U.S. FDA approved B. Braun Medical's Introcan Safety 2 Deep Access IV Catheter, which extends the catheter's dwell time from approximately 3.8 days to about 5.7 days. This product reduces blood exposure and cleanup through advanced safety features and targets patients with difficult vascular access. In August 2024, Brazil’s Secretariat of International Trade (SECEX) initiated an antidumping investigation against hypodermic needle imports from China, following a complaint by Becton Dickinson Indústrias Cirúrgicas Ltda., focusing on products under NCM code 9018.32.19 with an alleged dumping margin of USD 16.93/kg (261.7%). Public participation in the investigation was invited by September 17, 2024.

Key Players

• B. Braun Medical
• Becton Dickinson Indústrias Cirúrgicas Ltda.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.